Absence of EPAC1 Signaling to Stabilize CFTR in Intestinal Organoids

被引:2
|
作者
Ferreira, Joao F. [1 ]
Silva, Iris A. L. [1 ]
Botelho, Hugo M. [1 ]
Amaral, Margarida D. [1 ]
Farinha, Carlos M. [1 ]
机构
[1] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, P-1749016 Lisbon, Portugal
关键词
CFTR; Cystic Fibrosis; cAMP signaling; EPAC1; membrane stability; intestinal organoids; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; ACTIN CYTOSKELETON; CAMP; MEMBRANE; MECHANISM; ENDOCYTOSIS; ACTIVATION; FAMILY;
D O I
10.3390/cells11152295
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The plasma membrane (PM) stability of the cystic fibrosis transmembrane conductance regulator (CFTR), the protein which when mutated causes Cystic Fibrosis (CF), relies on multiple interaction partners that connect CFTR to signaling pathways, including cAMP signaling. It was previously shown that activation of exchange protein directly activated by cAMP 1 (EPAC1) by cAMP promotes an increase in CFTR PM levels in airway epithelial cells. However, the relevance of this pathway in other tissues, particularly the intestinal tissue, remains uncharacterized. Here, we used Western blot and forskolin-induced swelling assay to demonstrate that the EPAC1 protein is not expressed in the intestinal organoid model, and consequently the EPAC1 stabilization pathway is not in place. On the other hand, using cell surface biotinylation, EPAC1-mediated stabilization of PM CFTR is observed in intestinal cell lines. These results indicate that the EPAC1 stabilization pathway also occurs in intestinal cells and is a potential target for the development of novel combinatorial therapies for treatment of CF.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Controlling brown adipose tissue size through EPAC1
    Villarroya, Francesc
    Giralt, Marta
    NATURE REVIEWS ENDOCRINOLOGY, 2024, 20 (05) : 259 - 260
  • [42] EPAC1 enhances brown fat growth and beige adipogenesis
    Reverte-Salisa, Laia
    Siddig, Sana
    Hildebrand, Staffan
    Yao, Xi
    Zurkovic, Jelena
    Jaeckstein, Michelle Y.
    Heeren, Joerg
    Lezoualc'h, Frank
    Krahmer, Natalie
    Pfeifer, Alexander
    NATURE CELL BIOLOGY, 2024, 26 (01) : 113 - +
  • [43] Is Epac1 a good therapeutic strategy against cardiac remodelling?
    Pereira, Laetitia
    CARDIOVASCULAR RESEARCH, 2019, 115 (01) : 1 - 3
  • [44] Regulation of the inflammatory response of vascular endothelial cells by EPAC1
    Parnell, Euan
    Smith, Brian O.
    Palmer, Timothy M.
    Terrin, Anna
    Zaccolo, Manuela
    Yarwood, Stephen J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (02) : 434 - 446
  • [45] GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure
    Laudette, Marion
    Formoso, Karina
    Lezoualc'h, Frank
    CELLS, 2021, 10 (01) : 1 - 17
  • [46] The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology
    Bouvet, Marion
    Blondeau, Jean-Paul
    Lezoualc'h, Frank
    CELLS, 2019, 8 (12)
  • [47] Role of EPAC1 Signalosomes in Cell Fate: Friends or Foes?
    Formoso, Karina
    Lezoualc'h, Frank
    Mialet-Perez, Jeanne
    CELLS, 2020, 9 (09)
  • [48] Epac1 activates migration of melanoma and angiogenesis of endothelial cells via FGF-2 intercellular signaling
    Baljinnyam, Erdene
    Umemura, Masanari
    De Lorenzo, Mariana S.
    Iwatsubo, Kousaku
    CANCER RESEARCH, 2011, 71
  • [49] EPAC1 enhances brown fat growth and beige adipogenesis
    Laia Reverte-Salisa
    Sana Siddig
    Staffan Hildebrand
    Xi Yao
    Jelena Zurkovic
    Michelle Y. Jaeckstein
    Joerg Heeren
    Frank Lezoualc’h
    Natalie Krahmer
    Alexander Pfeifer
    Nature Cell Biology, 2024, 26 (1) : 113 - 123
  • [50] Controlling brown adipose tissue size through EPAC1
    Francesc Villarroya
    Marta Giralt
    Nature Reviews Endocrinology, 2024, 20 : 259 - 260